Cargando…

Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study

BACKGROUND: Triple-negative breast cancer (TNBC) with a BRCA1-like molecular signature has been demonstrated to remarkably respond to platinum-based chemotherapy and might be suited for a future treatment with poly(ADP-ribose)polymerase (PARP) inhibitors. In order to rapidly assess this signature we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gross, Eva, van Tinteren, Harm, Li, Zhou, Raab, Sandra, Meul, Christina, Avril, Stefanie, Laddach, Nadja, Aubele, Michaela, Propping, Corinna, Gkazepis, Apostolos, Schmitt, Manfred, Meindl, Alfons, Nederlof, Petra M., Kiechle, Marion, Lips, Esther H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070367/ https://www.ncbi.nlm.nih.gov/pubmed/27756336 http://dx.doi.org/10.1186/s12885-016-2848-2

Ejemplares similares

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
por: Lips, Esther H, et al.
Publicado: (2011)

Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers
por: Gross, E, et al.
Publicado: (2013)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
por: Vollebergh, Marieke A, et al.
Publicado: (2014)

Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses
por: Herman, Sandra, et al.
Publicado: (2012)

Three Cases of False-positive Multiplex Ligation-dependent Probe Amplification of BRCA1
por: Kim, Kyoung Bo, et al.
Publicado: (2022)

Detection of exon skipping events in BRCA1 RNA using MLPA kit P002
por: Brandão, Rita D., et al.
Publicado: (2012)

Multiplex ligation-dependent probe amplification (MLPA) enhances the molecular diagnosis of aniridia and related disorders
por: Redeker, Egbert J.W., et al.
Publicado: (2008)

Can we rely on the multiplex ligation-dependent probe amplification method (MLPA) for prenatal diagnosis?
por: Omrani, Mir Davood, et al.
Publicado: (2014)

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
por: Rhiem, Kerstin, et al.
Publicado: (2012)

Incidental finding at methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA): how to proceed?
por: Manero-Azua, Africa, et al.
Publicado: (2023)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

MLPAinter for MLPA interpretation: an integrated approach for the analysis, visualisation and data management of Multiplex Ligation-dependent Probe Amplification
por: van Eijk, Ronald, et al.
Publicado: (2010)

Detection of Partial Deletions of Y-chromosome AZFc in Infertile Men Using the Multiplex Ligation-dependent Probe Amplification Assay
por: Bunyan, David J., et al.
Publicado: (2012)

A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA)
por: Pedersen, Kristina, et al.
Publicado: (2010)

Detection of Aneuploidies in Products of Conception and Neonatal Deaths in Iranian Patients Using the Multiplex Ligation-Dependent Probe Amplification (MLPA)
por: Khorami Sarvestani, Sara, et al.
Publicado: (2021)

Probe-specific mixed-model approach to detect copy number differences using multiplex ligation-dependent probe amplification (MLPA)
por: González, Juan R, et al.
Publicado: (2008)

Multiplex ligation dependent probe amplification (MLPA) for rapid distinction between unique sequence positive and negative marker chromosomes in prenatal diagnosis
por: Van Opstal, Diane, et al.
Publicado: (2011)

Deletions within COL11A1 in Type 2 stickler syndrome detected by multiplex ligation-dependent probe amplification (MLPA)
por: Vijzelaar, Raymon, et al.
Publicado: (2013)

Genetic testing in Indian patients with Prader-Willi syndrome using methylation specific multiplex ligation dependent probe amplification (MS-MLPA)
por: Khadilkar, Vaman, et al.
Publicado: (2015)

Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia
por: Bashton, Matthew, et al.
Publicado: (2020)

Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation
por: de Jong, Vincent M. T., et al.
Publicado: (2022)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
por: Heublein, Sabine, et al.
Publicado: (2015)

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
por: Lips, E H, et al.
Publicado: (2013)

Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH)
por: Alhourani, Eyad, et al.
Publicado: (2014)

Large Deletions in the BRCA1 Gene Are Not Common in a Set of Familial German Breast Cancer Patients
por: Maringa, M., et al.
Publicado: (1999)

Identification of Chromosome Abnormalities in Subtelomeric Regions Using Multiplex Ligation Dependent Probe Amplification (MLPA) Technique in 100 Iranian Patients With Idiopathic Mental Retardation
por: Behjati, Farkhondeh, et al.
Publicado: (2013)

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
por: Lips, Esther H., et al.
Publicado: (2020)

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
por: Holstege, Henne, et al.
Publicado: (2010)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2
por: Schenk, Desiree, et al.
Publicado: (2017)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

Epistatic Relationships in the BRCA1-BRCA2 Pathway
por: Scully, Ralph
Publicado: (2011)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

BRCA1 tumor suppression occurs via heterochromatin mediated silencing
por: Zhu, Quan, et al.
Publicado: (2011)

Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
por: Heublein, Sabine, et al.
Publicado: (2017)

Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population
por: Fuka, Gerhard, et al.
Publicado: (2015)

Detection of HER2 Amplification in Breast Carcinomas: Comparison of Multiplex Ligation-Dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with Automated Spot Counting
por: Moerland, Elna, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_8ch693q9s4ardus00klq5b3olt